Patients with these severe clinical complications usually present modified plasmatic levels or alterations in coagulation parameters, thrombocytopenia, increased D-dimer, prolonged prothrombin time, or higher inflammatory protein levels such as C-reactive protein (CRP) and procalcitonin [7]. This evidence concerns the gene CRP and Thrombocytopenia.